世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4594 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、非ステロイド性抗炎症薬（NSAID）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他）、用途別市場規模（ドラッグストア、病院薬局、オンライン）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・非ステロイド性抗炎症薬（NSAID）の市場動向 ・企業の競争状況、市場シェア ・非ステロイド性抗炎症薬（NSAID）の種類別市場規模と予測2016-2027（アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他） ・非ステロイド性抗炎症薬（NSAID）の用途別市場規模と予測2016-2027（ドラッグストア、病院薬局、オンライン） ・非ステロイド性抗炎症薬（NSAID）の北米市場規模2016-2027（アメリカ、カナダ） ・非ステロイド性抗炎症薬（NSAID）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・非ステロイド性抗炎症薬（NSAID）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非ステロイド性抗炎症薬（NSAID）の中南米市場規模2016-2027（メキシコ、ブラジル） ・非ステロイド性抗炎症薬（NSAID）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche (Genentech)、Amgen、B-MS、Merck、Pfizer、Novartis、Eli Lilly and Company、Johnson & Johnson、GSK、Sanofi、Boehringer Ingelheim、Zhejiang Jiuzhou Pharmaceutical） ・結論

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

Market Analysis and Insights: Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market.

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Scope and Market Size
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others

Segment by Application
Drug Store
Hospital Pharmacies
Online

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Celecoxib
1.2.6 Others
1.3 Market by Application
1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2016-2027)
2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2016-2021)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2022-2027)
2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Dynamic
2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
2.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
2.3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue
3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2016-2021)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2016-2021)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2020
3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.6 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.7 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2016-2021)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2022-2027)

5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2016-2021)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
6.2.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
6.2.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
6.2.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
6.3.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
6.3.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
6.4.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
6.4.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
7.2.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
7.2.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
7.2.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
7.3.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
7.3.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
7.4.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
7.4.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
8.2.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
8.3.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
8.4.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
9.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
9.2.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
9.2.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
9.2.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
9.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
9.3.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
9.3.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
9.3.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
9.4 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
9.4.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
9.4.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
10.2.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
10.3.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
10.4.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche (Genentech)
11.1.1 Roche (Genentech) Company Details
11.1.2 Roche (Genentech) Business Overview
11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.1.5 Roche (Genentech) Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 B-MS
11.3.1 B-MS Company Details
11.3.2 B-MS Business Overview
11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.3.5 B-MS Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.9.5 GSK Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Aspirin
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Naproxen
Table 5. Key Players of Celecoxib
Table 6. Key Players of Others
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2016-2021)
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2022-2027)
Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2016-2021)
Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2020)
Table 20. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 24. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2016-2021)
Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2016-2021)
Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche (Genentech) Company Details
Table 65. Roche (Genentech) Business Overview
Table 66. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 67. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 68. Roche (Genentech) Recent Development
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 72. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. B-MS Company Details
Table 75. B-MS Business Overview
Table 76. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 77. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 78. B-MS Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 82. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 87. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 92. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 97. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 98. Eli Lilly and Company Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 102. Johnson & Johnson Recent Development
Table 103. GSK Company Details
Table 104. GSK Business Overview
Table 105. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 106. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 107. GSK Recent Development
Table 108. Sanofi Company Details
Table 109. Sanofi Business Overview
Table 110. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 111. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 112. Sanofi Recent Development
Table 113. Boehringer Ingelheim Company Details
Table 114. Boehringer Ingelheim Business Overview
Table 115. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 116. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 117. Boehringer Ingelheim Recent Development
Table 118. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 119. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 120. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 121. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 122. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2027
Figure 2. Aspirin Features
Figure 3. Ibuprofen Features
Figure 4. Naproxen Features
Figure 5. Celecoxib Features
Figure 6. Others Features
Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2027
Figure 8. Drug Store Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Case Studies
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2027
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2022-2027)
Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2020
Figure 17. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2020
Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2016-2021)
Figure 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2022-2027)
Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 23. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 24. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 25. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 29. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 30. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 31. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2016-2027)
Figure 41. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 49. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 50. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 51. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 57. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 62. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 68. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 70. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 71. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---